1Nabboltz J M,Canin J,CHANG J,et al. Phase Ⅲ trial comparing granulcvyte colony-stimulating fator to leridistim in the preven- tion of neutropenic complications in breast cancer patients trea- ted with docetaxel/doxorubicin/cyclophosphamide:resuhs of BCIR G004 tlJal [ J ]. Clin Breast Cancer, 2002,3 : 268.
7Martin M,Pienkowski T,Mackey J,et al.TAC improves disease free survival and overall survival over FAC in node positive early breast cancer patients,BRIRG001,55months follow up[J],presented at 26th Annual San Antonio Breast Cabcer Symposium,San Antonio,TX,2003,December 3.
8Early Breast Cancer Trialists' Collaborative Group:Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:An overview of the randomised trials[J].Lancet 2005,365:1687-1717.
9Nabholtz JM,Canin J,CHANG J,et al.Phase Ⅲ trial comparing granulocyte colony-stimulating fator to leridistim in the prevention of neutropenic complications in breast cancer patients treatd with docetsxel/doxorubicin/cyclophosphamide:results of BCIRG004 trial[J].Clin Breast Cancer,2002,3:268.
10Martin M,Pienkowski T,Mackey J,et al.Adjuvant docetaxel for node-positive breast cancer[J].New Engl J Med,2005; 352:2302 -2313.